FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies

Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):427-8. doi: 10.1007/s00259-006-0313-1. Epub 2006 Dec 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma / diagnostic imaging*
  • Carcinoma / secondary*
  • Carcinoma / therapy
  • Clinical Trials as Topic
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Lymphatic Metastasis
  • Neck
  • Neoplasms, Unknown Primary / diagnostic imaging*
  • Neoplasms, Unknown Primary / therapy
  • Positron-Emission Tomography / methods*
  • Positron-Emission Tomography / trends
  • Practice Patterns, Physicians' / trends
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18